| Net Cash Provided by (Used in) Operating Activities |
-11.9K |
USD |
+50.5% |
Q1 2023 |
Q1 2023 |
| Net Cash Provided by (Used in) Financing Activities |
69.7K |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
275M |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Common Stock, Shares, Issued |
38.2M |
shares |
+39.8% |
Q2 2024 |
Q2 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
49.2K |
USD |
|
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
562K |
USD |
+3940% |
Q2 2024 |
Q2 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
1.27M |
USD |
|
Q2 2024 |
Q2 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-59.4K |
USD |
|
Q2 2024 |
Q2 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
4.8M |
USD |
|
Q2 2024 |
Q2 2024 |
| Additional Paid in Capital |
7.32M |
USD |
+5.43% |
Q2 2024 |
Q2 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
| Interest Expense |
7.31K |
USD |
-0.03% |
Q3 2023 |
Q3 2023 |